Register for real-time alerts, custom portfolio, and market movers

Get Started

TARS Tarsus Pharmaceuticals Inc

34.51

-0.09 (-0.26%)

After Hours

Last Updated: 16:00:35

Delayed by 15 minutes

Tarsus completes enrollment in phase 3 study in eyelid disease; secures $175M credit line

To read the full story on Seeking Alpha, click here.

Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Tarsus Pharmaceuticals Charts.

Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Tarsus Pharmaceuticals Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Tarsus Pharmaceuticals Inc News

More Tarsus Pharmaceuticals Inc News Articles

Sincerity Applied Materi... (PK)

Marketing Worldwide (PK)

ProText Mobility (PK)

Clean Vision (QB)

Trump Media and Technology

CyberFuels (PK)

Branded Legacy (PK)

Moon Equity (PK)

AMC Entertainment

Lehman Brothers Financial (CE)

Delayed Upgrade Clock